Latest Transformation News

Hansen Technologies has raised its FY25 profitability outlook, driven by operational efficiencies and early powercloud profits, despite a slight revenue timing shift. The company also secured major new contracts across Europe and the US.

Imugene Limited reports promising Phase 1b trial results for azer-cel, an off-the-shelf CAR T therapy, showing a 75% overall response rate in relapsed diffuse large B-cell lymphoma patients. The company plans to engage the FDA later this year to discuss pivotal trial design.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Australian Strategic Materials unveils a transformative heap leach approach for its Dubbo Project, cutting upfront capital costs by over half and accelerating rare earth oxide production amid rising global demand.

InteliCare has launched a three-month trial of its AI-powered platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy with a leading aged care provider.

Mithril Silver and Gold Limited has arranged a placement to raise up to C$11.5 million, aiming to accelerate exploration at its Copalquin project in Mexico’s prolific Sierra Madre Trend.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Bryah Resources has exercised its option to acquire the Golden Pike gold and antimony project in New Brunswick, Canada, aiming to add significant value with a high-grade resource. The acquisition follows thorough due diligence and complements Bryah’s existing Australian portfolio.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Kingston Resources has received the first $50 million payment from the sale of its Misima Gold Project, bolstering its balance sheet and enabling a strategic pivot towards expanding its Australian copper operations.

Argosy Minerals has reached a key agreement to develop a 40MW energy infrastructure for its Rincon Lithium Project in Argentina, paving the way for expanded lithium production and enhanced project viability.